Gullberg & Jansson AB(DE:9D7)
€1.73+0.00 (+1.17%)
DE:9D7
Gullberg & Jansson AB stock drug pipeline
€1.73
At close:+0.00 (+1.17%)
Gullberg & Jansson AB (9D7) Drug Pipeline
0 Followers
This company reports no clinical trials.
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Gullberg & Jansson AB (DE:9D7) have in its pipeline
Gullberg & Jansson AB DE:9D7 does not currently report any drugs in clinical development.
